Skystar Launches Bovine Immunoglobulin G (IgG) Kits in China

Skystar Launches Bovine Immunoglobulin G (IgG) Kits in China 
XI'AN, CHINA -- (Marketwired) -- 07/08/14 --  Skystar
Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer
and distributor of veterinary medicine, vaccines, micro-organisms and
feed additives, today announced the launch of a new product in China
-- bovine immunoglobulin G (IgG) kits targeting China's domestic pig
farming communities. This product helps to prevent and treat blue ear
disease, respiratory pneumonia, pseudorabies, swine fever and foot
and mouth disease which are common diseases affecting pig in the
farming industry.  
Skystar's Chairman and CEO, Mr. Weibing Lu, commented, "Skystar is
pleased to launch its new bovine IgG kits in China. Having performed
market research with our customers, we anticipate that, the bovine
IgG kits, represent an approximate $1.5 million annual revenue
opportunity for Skystar, upon full production. The bovine IgG kits
will target and will be marketed to both small and medium scale pig
farms in China. Following our assessment of the needs of our
customers in the farming industry in China, we designed kits that
were intended to address the need for a product that treats the most
common diseases encountered in pig farming. Skystar will continue to
meet the challenge of developing its product lines for the changing
needs of China's animal husbandry industry which continually move
forward with modern industrialization and standardization of animal
husbandry practices. The Company believes that China's regulatory
environment encouraging new standards of food safety, will support
and create opportunities for its overall growth in the near to medium
term." 
Skystar's bovine immunoglobulin G (IgG) kits are comprised of a
proprietary formula of vitamin supplements including B1, B2, B6, and
niacin in combination with ATP, immune boosting antigen specific
transfer factor molecules and five different immunoglobulin (IgG) G
antibodies for the prevention and treatment of commonly occurring
diseases found in pig farming, including blue ear disease,
respiratory pneumonia, pseudorabies, swine fever and foot and mouth
disease. 
About Skystar Bio-Pharmaceutical Company 
Skystar is a China-based developer, manufacturer and distributor of
veterinary health
care and medical care products. Skystar has four
product lines: veterinary medicines, probiotics, vaccines and feed
additives formulated and packaged in house across several modern
manufacturing and distributions facilities. Skystar's distribution
network includes almost 3,000 distribution agents of which 360 are
franchised stores with exclusivity agreements covering 29 provinces
throughout China. For additional information, please visit
http://www.skystarbio-pharmaceutical.com. 
Safe Harbor Statements 
When used in this release, the words "intends," "believes,"
"anticipated" and "expects" and similar expressions are intended to
identify forward-looking statements. Forward-looking statements
include, without limitation, the Company's ability to complete the
launch of its IgG kits in the anticipated timeframe and to attain the
anticipated revenue and market penetration, as well as other related
efforts at the Huxian facilities, the Company's ability to timely,
effectively and accurately assess the efficacy and commercial
potential of any technologies that may results from such R&D efforts,
the Company's ability to realize the anticipated $1.5 million revenue
opportunity, the Company's ability to timely and effectively
commercialize any such technologies. Such statements are subject to
risks and uncertainties which could cause actual results to differ
materially from those projected. The Company undertakes no obligation
to publicly release the result of any revision to these
forward-looking statements which may be made to reflect the events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events. 
Contact: 
Skystar Bio-Pharmaceutical Company
Scott Cramer
Director - Corporate Development & U.S. Representative 
(407) 645-4433 
Taylor-Rafferty
Christopher Chu
(212) 889-4350
skystar@taylor-rafferty.com 
 
 
Press spacebar to pause and continue. Press esc to stop.